Page last updated: 2024-10-31

mirtazapine and Erythremia

mirtazapine has been researched along with Erythremia in 2 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verma, S1
Cikurel, K1
Koralnik, IJ1
Morgello, S1
Cunningham-Rundles, C1
Weinstein, ZR1
Bergmann, C1
Simpson, DM1
Focosi, D1
Kast, RE1
Maggi, F1
Lauria, G1
Ceccherini-Nelli, L1
Petrini, M1

Other Studies

2 other studies available for mirtazapine and Erythremia

ArticleYear
Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.
    The Journal of infectious diseases, 2007, Sep-01, Volume: 196, Issue:5

    Topics: Female; Humans; Leukoencephalopathy, Progressive Multifocal; Mianserin; Middle Aged; Mirtazapine; Po

2007
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
    The Journal of infectious diseases, 2008, Jan-15, Volume: 197, Issue:2

    Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middl

2008